Showing results (21-30 of 536) with videos related to

Sort By:
Pageof 54
The Journal of Pathology|July 26, 2005
Protective role of heat shock protein 27 in gastric mucosal injuryMatthias P A Ebert, Claus Schäfer, Jie Chen, et al.
Basic & Clinical Pharmacology & Toxicology|July 13, 2004
CYP2C19 polymorphism and proton pump inhibitorsUlrich Klotz, Matthias Schwab, Gerhard Treiber
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2009
Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter organic anion-transporting polypeptide 2A1 expressed in human gastroduodenal mucosaKathrin Mandery, Krystyna Bujok, Ingrid Schmidt, et al.
Digestive Diseases (Basel, Switzerland)|February 9, 2018
STW 5 (Iberogast) Therapy in Gastrointestinal Functional DisordersPeter Malfertheiner
Clinical Pharmacology and Therapeutics|September 17, 2004
CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pyloriMatthias Schwab, Elke Schaeffeler, Ulrich Klotz, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|July 9, 2009
Influence of Helicobacter pylori on gastric regulation of food intakeJochen Weigt, Peter Malfertheiner
Helicobacter|November 18, 2003
Helicobacter pylori and nonmalignant diseasesVassili Isakov, Peter Malfertheiner
Pageof 54